Journal of Cellular and Molecular Medicine,
Journal Year:
2020,
Volume and Issue:
25(2), P. 925 - 936
Published: Dec. 4, 2020
The
enhancer
of
zeste
homologue
2
(EZH2)
is
a
histone
H3
lysine
27
methyltransferase
that
promotes
tumorigenesis
in
variety
human
malignancies
by
altering
the
expression
tumour
suppressor
genes.
To
evaluate
prognostic
value
EZH2
glioma,
we
analysed
gene
data
and
corresponding
clinicopathological
information
from
Chinese
Glioma
Genome
Atlas,
Cancer
Atlas
GTEx.
Increased
was
significantly
associated
with
clinicopathologic
characteristics
overall
survival
as
evaluated
univariate
multivariate
Cox
regression.
Gene
Set
Enrichment
Analysis
revealed
an
association
cell
cycle,
DNA
replication,
mismatch
repair,
p53
signalling
pyrimidine
metabolism.
We
constructed
nomogram
for
prognosis
prediction
EZH2,
variables
correlated
demonstrated
to
be
several
immune
checkpoints
tumour-infiltrating
lymphocytes.
Furthermore,
ESTIMATE
Timer
Database
scores
indicated
correlation
more
immunosuppressive
microenvironment
glioblastoma
than
low
grade
glioma.
Overall,
our
study
demonstrates
potential
molecular
marker
poor
glioma
identifies
pathways
regulated
EHZ2,
suggesting
direction
future
application
therapy
JCO Clinical Cancer Informatics,
Journal Year:
2019,
Volume and Issue:
3, P. 1 - 13
Published: Feb. 4, 2019
Cancer
biology
involves
complex,
dynamic
interactions
between
cancer
cells
and
their
tissue
microenvironments.
Single-cell
effects
are
critical
drivers
of
clinical
progression.
Chemical
mechanical
communication
tumor
stromal
can
co-opt
normal
physiologic
processes
to
promote
growth
invasion.
cell
heterogeneity
increases
cancer's
ability
test
strategies
adapt
microenvironmental
stresses.
Hypoxia
treatment
select
for
stem
drive
invasion
resistance.
Cell-based
computational
models
(also
known
as
discrete
models,
agent-based
or
individual-based
models)
simulate
individual
they
interact
in
virtual
tissues,
which
allows
us
explore
how
single-cell
behaviors
lead
the
dynamics
we
observe
work
control
systems.
In
this
review,
introduce
broad
range
techniques
available
cell-based
modeling.
The
approaches
from
highly
detailed
just
a
few
morphologies
millions
simpler
three-dimensional
tissues.
Modeling
directly
translate
biologic
observations
into
simulation
rules.
many
cases,
agents
include
molecular-scale
models.
Most
also
transport
oxygen,
drugs,
factors,
allow
link
development
conditions.
We
illustrate
these
methods
with
examples
drawn
hypoxia,
angiogenesis,
invasion,
cells,
immunosurveillance.
An
ecosystem
interoperable
tools
is
emerging
at
time
when
cloud
computing
resources
make
software
easier
access
supercomputing
large-scale
studies
possible.
As
field
develops,
anticipate
that
high-throughput
will
rapidly
space
possibilities,
prescreen
new
therapeutic
strategies,
even
re-engineer
bring
systems
under
control.
International Journal of Molecular Sciences,
Journal Year:
2020,
Volume and Issue:
21(6), P. 1932 - 1932
Published: March 12, 2020
Glioblastoma
(GBM)
is
a
particularly
devastating
tumor
with
median
survival
of
about
16
months.
Recent
research
has
revealed
novel
insights
into
the
outstanding
heterogeneity
this
type
brain
cancer.
However,
all
GBM
subtypes
share
hallmark
feature
aggressive
invasion
surrounding
tissue.
Invasive
glioblastoma
cells
escape
surgery
and
focal
therapies
thus
represent
major
obstacle
for
curative
therapy.
This
review
aims
to
provide
comprehensive
understanding
glioma
mechanisms
respect
tumor-cell-intrinsic
properties
as
well
cues
provided
by
microenvironment.
We
discuss
genetic
programs
that
may
influence
dissemination
plasticity
their
different
patterns.
also
how
shape
microenvironment
how,
vice
versa,
components
extracellular
matrix
factors
from
non-neoplastic
cell
motility.
further
platforms
modeling
invasion.
Finally,
we
highlight
importance
accounting
complex
interplay
between
treatment
resistance
in
when
considering
new
therapeutic
approaches.
Cells,
Journal Year:
2019,
Volume and Issue:
8(8), P. 863 - 863
Published: Aug. 9, 2019
Glioblastoma
multiforme
is
the
most
aggressive
malignant
tumor
of
central
nervous
system.
Due
to
absence
effective
pharmacological
and
surgical
treatments,
identification
early
diagnostic
prognostic
biomarkers
key
importance
improve
survival
rate
patients
develop
new
personalized
treatments.
On
these
bases,
aim
this
review
article
summarize
current
knowledge
regarding
application
molecular
biology
proteomics
techniques
for
novel
through
analysis
different
biological
samples
obtained
from
glioblastoma
patients,
including
DNA,
microRNAs,
proteins,
small
molecules,
circulating
cells,
extracellular
vesicles,
etc.
Both
benefits
pitfalls
analyses
are
discussed,
mass
spectrometry-based
analytical
techniques,
highlighting
how
investigation
strategies
powerful
tools
study
glioblastoma,
as
well
advanced
methods
management
pathology.
Processes,
Journal Year:
2019,
Volume and Issue:
7(1), P. 37 - 37
Published: Jan. 13, 2019
Multiscale
systems
biology
and
pharmacology
are
powerful
methodologies
that
playing
increasingly
important
roles
in
understanding
the
fundamental
mechanisms
of
biological
phenomena
clinical
applications.
In
this
review,
we
summarize
state
art
applications
agent-based
models
(ABM)
hybrid
modeling
to
tumor
immune
microenvironment
cancer
response,
including
immunotherapy.
Heterogeneity
is
a
hallmark
cancer;
heterogeneity
at
molecular,
cellular,
tissue
scales
major
determinant
metastasis,
drug
resistance,
low
response
rate
molecular
targeted
therapies
immunotherapies.
Agent-based
an
effective
methodology
obtain
understand
quantitative
characteristics
these
processes
propose
solutions
aimed
overcoming
current
obstacles
treatment.
We
review
focusing
on
intra-tumor
heterogeneity,
particularly
interactions
between
cells
stromal
cells,
role
tumor-associated
vasculature
immune-related
mechanobiology,
discuss
digital
pathology
parameterizing
validating
spatial
computational
potential
therapeutics.
Pharmacology,
Journal Year:
2023,
Volume and Issue:
108(5), P. 423 - 431
Published: Jan. 1, 2023
Background:
Glioblastoma
multiforme
(GBM)
is
a
WHO
grade
4
glioma
and
the
most
common
malignant
primary
brain
tumour.
Recently,
there
has
been
outstanding
progress
in
treatment
of
GBM.
In
addition
to
newest
form
GBM
removal
using
fluorescence,
three-dimensional
(3D)
imaging,
tomoradiotherapy,
moderate
electro-hyperthermia,
adjuvant
temozolomide
(post-operative
chemotherapy),
new
developments
have
made
fields
immunology,
molecular
biology,
virotherapy.
An
unusual
modern
created,
especially
for
stage
GBM,
latest
therapeutic
techniques,
including
immunotherapy
Modern
oncological
medicine
producing
extraordinary
progressive
methods.
Oncological
therapy
includes
individual
analysis
properties
tumour
targeted
small-molecule
inhibitors.
Individualised
covers
entire
patient
(tumour
host)
context
immunotherapy.
example
individualised
multimodal
(IMI),
which
relies
on
immunological
tumour-host
interactions.
addition,
IMI
based
concept
oncolytic
virus-induced
immunogenic
cell
death.
Summary:
this
review,
we
outline
current
knowledge
various
available
options
used
both
traditional
strategy
therapies,
such
as
tomotherapy,
virotherapy,
are
promising
strategies
with
potential
improve
prognosis
patients
Key
Messages:
This
therapy,
combined
virotherapy
(oncolytic
viruses
cancer
vaccines),
displaying
encouraging
signs
combating
Additionally,
3D
imaging
compared
conventional
two-dimensional
imaging.
IEEE Transactions on Medical Imaging,
Journal Year:
2019,
Volume and Issue:
38(8), P. 1875 - 1884
Published: Feb. 27, 2019
Glioblastoma
(GBM)
is
a
highly
invasive
brain
tumor,
whose
cells
infiltrate
surrounding
normal
tissue
beyond
the
lesion
outlines
visible
in
current
medical
scans.
These
infiltrative
are
treated
mainly
by
radiotherapy.
Existing
radiotherapy
plans
for
tumors
derive
from
population
studies
and
scarcely
account
patient-specific
conditions.
Here,
we
provide
Bayesian
machine
learning
framework
rational
design
of
improved,
personalized
using
mathematical
modeling
patient
multimodal
Our
method,
first
time,
integrates
complementary
information
high-resolution
MRI
scans
specific
FET-PET
metabolic
maps
to
infer
tumor
cell
density
GBM
patients.
The
quantifies
imaging
uncertainties
predicts
with
credible
intervals.
proposed
methodology
relies
only
on
data
acquired
at
single
time
point
and,
thus,
applicable
standard
clinical
settings.
An
initial
study
shows
that
generated
inferred
infiltration
spare
more
healthy
thereby
reducing
radiation
toxicity
while
yielding
comparable
accuracy
protocols.
Moreover,
regions
high
densities
coincide
radioresistant
areas,
providing
guidance
dose-escalation.
integration
provides
robust,
non-invasive
tool
assist
design.
Cancers,
Journal Year:
2018,
Volume and Issue:
11(1), P. 17 - 17
Published: Dec. 22, 2018
Glioma
is
the
most
aggressive
brain
tumor
of
central
nervous
system.
The
ability
glioma
cells
to
migrate,
rapidly
diffuse
and
invade
normal
adjacent
tissue,
their
sustained
proliferation,
heterogeneity
contribute
an
overall
survival
approximately
15
months
for
patients
with
high
grade
glioma.
Numerous
studies
indicate
that
non-coding
RNA
species
have
critical
functions
across
biological
processes
regulate
initiation
progression.
Recently,
new
data
emerged,
which
shows
cross-regulation
between
long
RNAs
small
phenotypic
diversity
glioblastoma
subclasses.
In
this
paper,
we
review
expression,
was
evaluated
in
human
tissue
samples
during
a
five-year
period.
Thus,
summarizes
following:
(I)
role
pathogenesis,
(II)
potential
application
glioma-grading,
(III)
crosstalk
lncRNAs
miRNAs
(IV)
future
perspectives
as
biomarkers
PLoS Computational Biology,
Journal Year:
2020,
Volume and Issue:
16(3), P. e1007635 - e1007635
Published: March 10, 2020
The
Hybrid
Automata
Library
(HAL)
is
a
Java
developed
for
use
in
mathematical
oncology
modeling.
It
made
of
simple,
efficient,
generic
components
that
can
be
used
to
model
complex
spatial
systems.
HAL's
broadly
classified
into:
on-
and
off-lattice
agent
containers,
finite
difference
diffusion
fields,
GUI
building
system,
additional
tools
utilities
computation
data
collection.
These
are
designed
operate
independently
standardized
make
them
easy
interface
with
one
another.
As
demonstration
how
modeling
simplified
using
our
approach,
we
have
included
complete
example
hybrid
(a
interacting
agent-based
PDE
components).
HAL
useful
asset
researchers
who
wish
build
performant
1D,
2D
3D
models
Java,
while
not
starting
entirely
from
scratch.
available
on
GitHub
at
https://github.com/MathOnco/HAL
under
the
MIT
License.
requires
JDK
version
1.8
or
later
compile
run
source
code.
Advanced Drug Delivery Reviews,
Journal Year:
2021,
Volume and Issue:
174, P. 265 - 293
Published: April 23, 2021
Pancreatic
ductal
adenocarcinoma
(PDAC)
is
an
extremely
aggressive
type
of
cancer
with
overall
survival
rate
less
than
7–8%,
emphasizing
the
need
for
novel
effective
therapeutics
against
PDAC.
However
only
a
fraction
which
seemed
promising
in
laboratory
environment
will
eventually
reach
clinic.
One
main
reasons
behind
this
low
success
complex
tumor
microenvironment
(TME)
PDAC,
highly
fibrotic
and
dense
stroma
surrounding
cells,
supports
progression
as
well
increases
resistance
treatment.
In
particular,
growing
understanding
PDAC
TME
points
out
different
challenge
development
efficient
–
lack
biologically
relevant
vitro
vivo
models
that
resemble
complexity
heterogeneity
observed
patients.
The
purpose
scope
review
to
provide
overview
recent
developments
models,
aim
recapitulate
environment,
describe
how
3D
can
be
integrated
into
drug
pipelines
are
already
including
sophisticated
models.
Hereby
special
focus
given
on
challenges
face
same
levels
controllable
manner.
First,
brief
introduction
two
dimensional
(2D)
ex
provided.
Next,
three
(3D)
described
ranging
from
spheroids,
organoids,
scaffold
bioprinted
organ-on-chip
discussion
advantages
limitations
each
model.
Furthermore,
we
detailed
current
chemically-induced
syngeneic
xenogeneic
highlighting
hetero-
orthotopic,
patient-derived
tissues
(PDX)
genetically
engineered
mouse
Finally,
both,
discuss
necessary
steps
overcome
these
pipeline,
possibilities
include
silico
process.